Wet skin thoroughly with water
CJC-1295/Ipamorelin = none (Ipamorelins selectivity preserves the clean profile)
A comprehensive overview of peptide side effects in research settings provides additional context for research safety planning
Between 1993 and 1995, on behalf of the Eastern Cooperative Oncology Group, patients with advanced breast adenocarcinoma (metastasized or locally advanced), who had undergone prior chemotherapeutic regimens (containing neither taxanes nor doxorubicin) in a time frame not inferior to at least 6 months, were enrolled in a trial comparing PTX (175 mg/m 2 /24h), doxorubicin (60 mg/m 2 ), or a combined regimen (PTX 150 mg/m 2 /24h, doxorubicin 50 mg/m 2 , and prophylactic granulocyte-colony stimulating factor) with infusions every 3 weeks
For this review, we selected a broad range of models, including rodents (mice, rats), pigs, the fish Danio rerio and the invertebrate Drosophila melanogaster (Table 3)
doi: 10.1016/j.nbd.2021.105360 236 RothsteinJ
